Download Full Text (425 KB)


Aim: Embedded clinical pharmacists within primary care clinics optimize pharmacologic care for patients with high-risk disease states including Type 2 Diabetes Mellitus (T2DM) and established cardiovascular disease. Glucagon-like peptide 1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter 2 inhibitors (SGLT2i) are two classes of evidence-based therapies for these indications. However, medication access is a common barrier for these medications due to high cost, drug shortages, and need for insurance prior authorizations. The overall goal of this initiative was to improve access and increase utilization of GLP-1 RA and SGLT2i by: Improving teamwork and communication between key internal teams to help patients access GLP-1 RA and SGLT2i; Assessing utilization of Henry Ford Pharmacies for GLP-1 RA and SGLT2i in clinics with embedded clinical pharmacists; Describing the impact of the patient care team on connecting patients to the Henry Ford Pharmacy Patient Financial Assistance Program (HF PFAP).

Publication Date



Henry Ford Health


Detroit, Michigan


Quality Expo, posters, poster competition

Project #62: Collaboration is Key: Embedded Clinical Pharmacists in Primary Care Clinics Collaborate to Help Patients with Diabetes and Cardiovascular Risk



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.